AKT1 and metabolic dysfunction-associated steatotic liver disease: In vitro, combined with the results of western blot that after knocking down EGFR, the expression of PI3K and AKT also decreased accordingly, we speculated that lycorine could target EGFR and affect the PI3K/AKT signaling pathway to ameliorate MASLD.